MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor immune cells join fight against advanced nasal cancer
Disease control Not yet recruitingThis study tests whether adding Natural Killer (NK) cells from healthy donors to standard chemotherapy and radiation can lower the chance of cancer returning in people with advanced nasopharyngeal cancer. About 31 participants will receive different doses of NK cells to find the …
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 16, 2026 23:05 UTC
-
Could Pre-Surgery chemo boost colon cancer survival?
Disease control Not yet recruitingThis study compares giving chemotherapy before surgery versus standard surgery-first treatment for adults aged 18-70 with stage II or III colon cancer and high CEA levels. One hundred participants will be randomly assigned to either four cycles of CAPEOX chemo followed by surgery…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Blood test may predict liver cancer comeback and immunotherapy success
Knowledge-focused Not yet recruitingThis study looks at whether a blood test that detects tiny bits of tumor DNA (called minimal residual disease) can predict if liver cancer will come back after surgery. Researchers will test 276 patients before and after surgery to see if the test can also identify who might bene…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC